Why the study?
Does the monocyte-to-lymphocyte ratio predict MACE in patients with coronary heart disease?
Does the monocyte-to-lymphocyte ratio predict MACE in patients with coronary heart disease?
Answers are grounded in this paper and cite their sources.
The monocyte-to-lymphocyte ratio is a simple, widely available biomarker that can help prioritize high-risk CHD patients in emergency settings.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vakhshoori et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: